Correlative protection using ospa antibody titers

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/02 (2006.01) A61K 39/38 (2006.01) A61K 49/00 (2006.01) C07K 1/00 (2006.01) C07K 14/00 (2006.01) C07K 17/00 (2006.01) C12N 1/12 (2006.01) C12N 1/20 (2006.01) G01N 31/00 (2006.01) G01N 33/48 (2006.01) G01N 33/569 (2006.01) A61K 38/12 (2006.01)

Patent

CA 2332979

Methods of protecting human beings from infection by $(B. burgdorferi) are disclosed, which comprises internally administering lipoprotein OspA, or a combination of lipoprotein OspAs using specified dosing schedules.

L'invention concerne des méthodes de protection de l'homme contre une infection à Borrelia burgdorferi. Ces méthodes consistent à administrer par voie interne une lipoprotéine OspA ou une combinaison de lipoprotéine OspA en utilisant des dosages spécifiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Correlative protection using ospa antibody titers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Correlative protection using ospa antibody titers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Correlative protection using ospa antibody titers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2051450

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.